Patent · US Expired

LO-CD2b antibody

US6541611B1 · kind B1 · utility

1Cited by

3References

2Claims

0Family size

Assignee

UNIVERSITÉ CATHOLIQUE DE LOUVAIN · BE

Inventors

Herve Bazin · Brussels, BE
Dominique Latinne · Brussels, BE
Pierre Gianello · Rixensart, BE

Key dates

Filing date	Jun 14, 2000
Grant date	Apr 1, 2003
Priority date	—
Expiry date	Jun 14, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/732
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A monoclonal antibody which binds to baboon and human CD2, and in particular LO-CD2b antibody. The antibody may be employed to prevent and inhibit an immune response in human patients, such as when the immune response is mediated by the activation and proliferation of T-cells or natural killer cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.